Calendar EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Market Closed - Nasdaq 04:00:00 2024-04-15 pm EDT 5-day change 1st Jan Change
21.28 USD -5.21% Intraday chart for EyePoint Pharmaceuticals, Inc. +2.65% -7.92%

Chart calendar EyePoint Pharmaceuticals, Inc.

ad61690efc510d9b5621438563337de.vqpkJzq1rnkjIaLSS1WJAR0LO7oDfU878Y3KjYW9d8M.9e8nQXeHmjx8T9WLGmHCd0wyXM1pEnhPoufywbLWAq3UhzJAdt7qE3ATwQ~6730064feb25b57f73a5fd11cef86a7c

Upcoming events on EyePoint Pharmaceuticals, Inc.

2024-04-30 Q1 2024 Earnings Release (Projected)
2024-06-20 09:00 am Annual General Meeting
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on EyePoint Pharmaceuticals, Inc.

2024-03-13 09:15 am Guggenheim Healthy Altitudes Summit
2024-03-10 Leerink Partners Global Biopharma Conference
2024-03-07 08:30 am Q4 2023 Earnings Call
2024-03-07 07:00 am Q4 2023 Earnings Release
2024-03-05 10:30 am TD Cowen Health Care Conference
2024-02-07 12:30 pm Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat
2024-01-10 01:30 pm JPMorgan Healthcare Conference
2023-12-04 08:00 am DAVIO 2 Phase 2- Trial Results Call
2023-11-09 08:00 am Investor Meeting - Key Opinion Leader
2023-11-07 02:30 pm Guggenheim Securities Inflammation & Immunology Conference
2023-11-03 11:00 am American Academy Of Ophthalmology Meeting
2023-11-02 11:10 am Eyecelerator Conference - Panel
2023-11-01 08:30 am Q3 2023 Earnings Call
2023-11-01 07:00 am Q3 2023 Earnings Release
2023-10-10 01:45 pm JonesTrading Healthcare Summit
2023-09-26 12:25 pm Cantor Global Healthcare Conference - Fireside Chat
2023-09-13 12:50 pm Baird Global Healthcare Conference - Fireside Chat
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-09-05 Citi BioPharma Conference
2023-08-16 11:00 am H.C. Wainwright Ophthalmology Virtual Conference - Panel

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
20,4
19,0
7.33%
34,4
45,6
-24.47%
36,9
35,2
4.97%
41,4
41,3
0.31%
46,0
40,5
13.59%

38,1

EBITDA
Million USD
Released
Forecast
Spread
-40,7
-44,8
9.26%
-34,6
-15,0
-130.94%
0,00
0,00
-
0,00
0,00
-
0,00
119
-

160

EBIT
Million USD
Released
Forecast
Spread
-47,9
-50,0
4.32%
-37,3
-24,7
-50.96%
-55,3
-52,0
-6.31%
-78,9
-78,6
-0.46%
-75,1
-81,3
7.63%

-100

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-56,8
-59,0
3.82%
-45,4
-36,3
-25.05%
-58,4
-55,2
-5.91%
-102
-82,2
-24.42%
-70,7
-76,6
7.69%

-87,5

Net income
Million USD
Released
Forecast
Spread
-56,8
-59,0
3.82%
-45,4
-36,3
-25.05%
-58,4
-55,2
-5.91%
-102
-82,2
-24.42%
-70,8
-76,6
7.56%

-89,3

EPS
USD
Released
Forecast
Spread
-5,40
-5,65
4.42%
-3,54
-2,13
-66.04%
-2,03
-1,99
-2.27%
-2,74
-2,19
-25.23%
-1,82
-1,92
5.4%

-1,77

Announcement Date05/03/2004/03/2103/03/2202/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
11,5
9,79
17.9%
9,29
9,89
-6%
11,6
10,9
6.45%
10,0
10,9
-8.32%
10,5
10,4
1.25%
7,68
7,57
1.54%
9,11
42,1
-78.39%
15,2
7,43
104.6%
14,0
8,70
61.18%

8,93


8,79


9,31


8,23

EBITDA
Million USD
Released
Forecast
Spread

























31,0


33,0


37,0


42,0


47,0

EBIT
Million USD
Released
Forecast
Spread
-18,1
-14,8
-22.07%
-18,3
-18,5
1.14%
-19,2
-18,8
-2.3%
-18,4
-25,4
27.51%
-23,0
-22,6
-1.95%
-21,6
-25,2
14.42%
-22,8
4,77
-577.27%
-14,4
-20,1
28.26%
-16,4
-22,3
26.68%

-21,5


-23,2


-26,0


-29,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-19,4
-16,2
-20.21%
-21,0
-19,3
-8.59%
-19,4
-19,1
-1.84%
-18,4
-25,2
26.95%
-43,5
-23,4
-85.83%
-21,2
-25,9
18.43%
-22,9
12,4
-284.93%
-12,6
-18,7
32.43%
-14,0
-19,9
29.44%

-18,4


-20,2


-23,0


-26,2

Net income
Million USD
Released
Forecast
Spread
-19,4
-16,2
-20.21%
-21,0
-19,3
-8.59%
-19,4
-19,1
-1.84%
-18,4
-25,2
26.95%
-43,5
-23,4
-85.83%
-21,2
-25,9
18.43%
-22,9
12,4
-284.93%
-12,6
-18,7
32.43%
-14,1
-19,9
29.03%

-18,4


-20,2


-23,0


-26,2

EPS
USD
Released
Forecast
Spread
-0,59
-0,56
-5.83%
-0,56
-0,56
0%
-0,52
-0,51
-1.96%
-0,49
-0,65
25.08%
-1,16
-0,62
-88.31%
-0,56
-0,69
18.45%
-0,61
0,57
-207.02%
-0,33
-0,48
31.72%
-0,33
-0,49
32.26%

-0,36


-0,40


-0,45


-0,55

Announcement Date03/03/2204/05/2203/08/2202/11/2202/03/2303/05/2302/08/2301/11/2307/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EYPT Stock
  4. Calendar EyePoint Pharmaceuticals, Inc.